Status:
COMPLETED
ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children
Lead Sponsor:
Tongji Hospital
Conditions:
Bidirectional Endoscopy
Eligibility:
All Genders
Up to 12 years
Phase:
NA
Brief Summary
Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups.
Detailed Description
Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups, providing a more scientific clinical dose selection basis for the anesthesia induction application of Re...
Eligibility Criteria
Inclusion
- Age 0-12 years old,
- ASA I-II level;
- Sign an informed consent form.
Exclusion
- Developmental delay or neurological and psychiatric disorders;
- Severe malnutrition or severe obesity;
- High risk of stomach fullness and reflux aspiration;
- Allergic to benzodiazepines and opioids;
- Those who have taken sedative, analgesic, or antidepressant drugs within 24 hours;
- Severe sleep apnea;
- Abnormal liver and kidney function;
- Recently participated in other clinical studies.
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT06121609
Start Date
January 15 2024
End Date
April 30 2024
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430000